Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T‐cell leukaemia‐lymphoma. (3rd April 2017) - Tokunaga, Masahito; Yonekura, Kentaro; Nakamura, Daisuke; Haraguchi, Kouichi; Tabuchi, Tomohisa; Fujino, Satoshi; Hayashida, Maiko; Maekawa, Kenichi; Arai, Akihiko; Nakano, Nobuaki; Kamada, Yuhei; Kubota, Ayumu; et al.